(Bloomberg) -- US President Donald Trump is planning to slap tariffs on goods from Canada and Mexico on Saturday. Now comes the guessing game of how they will affect the global stock market.Most Read from BloombergHow the 2025 Catholic Jubilee Is Reshaping RomeTrump Paves the Way to Deputize Local Police on ImmigrationWhen French Communists Went on a Brutalist Building BoomHistoric London Elevator Faces Last Stop in Labour’s Housing PushManhattan’s Morning Commute Time Drops With New Congestion
A Blueprint for Crypto Market Structure
Kristin Smith, CEO of the Blockchain Association, outlines principles to guide legislation and regulation on issues like self-custody, staking, voting, and peer-to-peer transactions on permissionless networks.
Trump says oil and gas tariffs will come around Feb 18
U.S. President Donald Trump said on Friday he expects his administration to impose tariffs related to oil and gas around Feb. 18. He did not name a specific country to which the tariffs would apply or specify any more details about the plans. "We're going to put tariffs on oil and gas," Trump told reporters in the White House's Oval Office.
Why Analysts Think AI Could Be Key to More Apple Stock Gains
After Apple CEO Tim Cook said the iPhone maker is seeing record iPhone upgrades with the rollout of Apple Intelligence, several analysts raised their price targets for the company's stock, pointing to AI updates as a potential source of growth.
AbbVie (NYSE:ABBV) Posts Better-Than-Expected Sales In Q4, Stock Soars
Pharmaceutical company AbbVie (NYSE:ABBV) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 5.6% year on year to $15.1 billion. Its non-GAAP profit of $2.16 per share was 4.3% below analysts’ consensus estimates.
ResMed (NYSE:RMD) Posts Better-Than-Expected Sales In Q4 But Stock Drops
Medical device company ResMed (NYSE:RMD) announced better-than-expected revenue in Q4 CY2024, with sales up 10.3% year on year to $1.28 billion. Its non-GAAP profit of $2.43 per share was 5.2% above analysts’ consensus estimates.
Intuitive Surgical (NASDAQ:ISRG) Delivers Impressive Q4
Medical technology company Intuitive Surgical (NASDAQ:ISRG) announced better-than-expected revenue in Q4 CY2024, with sales up 25.2% year on year to $2.41 billion. Its non-GAAP profit of $2.21 per share was 23.8% above analysts’ consensus estimates.